Literature DB >> 18489622

Cracking the whip on childhood mortality--role of the specialized neonatal unit in Eritrea.

O Zemichael1, P Nyarang'o, J Mufunda.   

Abstract

UNLABELLED: Health care services in developing countries are being challenged by high childhood mortality rates. Although there have been tremendous strides made in reducing infant mortality rates largely due to vaccinations and improved standards of living, a lot remains to be done to reduce neonatal mortality. Achievement of the Millennium Development Goal (MDG) number 4 on childhood mortality will remain unattainable in most developing countries unless purpose based interventions targeted at reducing neonatal mortality are instituted. This viewpoint is based on the experiences gained in Eritrea, a country that gained independence less than twenty years ago following a protracted war that left a trail of destruction of infrastructure in general and health facilities in particular. War that broke out with Ethiopia less than 10 years into its independence and border conflicts followed by a no peace no war stalemate situation aggravated by frequent droughts have continued to throttle economic recovery, reconstruction and rehabilitative efforts. The population is estimated at 3.5 million comprising of nine ethnic groups who speak different languages. The country has a surface area of 124,000 km2 which shares borders with Sudan, Ethiopia, Djibouti and the Red Sea.
CONCLUSION: Attainment of the MDG number 4 on reduction of childhood mortality can be achieved by addressing morbidities of the neonate where the bottle neck currently appears to be sited.

Entities:  

Mesh:

Year:  2008        PMID: 18489622     DOI: 10.1111/j.1651-2227.2008.00818.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  1 in total

1.  Factors associated with mortality and length of stay in hospitalised neonates in Eritrea, Africa: a cross-sectional study.

Authors:  Shetal Shah; O Zemichael; Hong Dao Meng
Journal:  BMJ Open       Date:  2012-09-14       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.